Comparing Dexmethylphenidate vs Dexmethylphenidate / Serdexmethylphenidate
| Dexmethylphenidate | Dexmethylphenidate / serdexmethylphenidate |
|
|---|
| Dexmethylphenidate | Dexmethylphenidate / serdexmethylphenidate |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Dexmethylphenidate improves symptoms of ADHD but carries with it a risk of dependence. It is twice as potent as methylphenidate. Prescribed for Auditory Processing Disorder, ADHD. Dexmethylphenidate... View more |
Prescription only
Prescribed for ADHD. Dexmethylphenidate / serdexmethylphenidate may also be used for purposes not listed in this medication guide. |
Related suggestions ADHD (Attention Deficit Hyperactivity Disorder)
Popular comparisons
|
|||||||
| More about Dexmethylphenidate | More about Dexmethylphenidate / serdexmethylphenidate | ||||||||
| Ratings & Reviews | |||||||||
|
Dexmethylphenidate has an average rating of 6.1 out of 10 from a total of 300 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 32% reported a negative effect. |
Dexmethylphenidate / serdexmethylphenidate has an average rating of 7.4 out of 10 from a total of 41 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Dexmethylphenidate side effects |
View all Dexmethylphenidate / serdexmethylphenidate side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Dexmethylphenidate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Focalin, Focalin XR | Azstarys | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
3 hours |
11.7 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 204 drugs are known to interact with Dexmethylphenidate:
|
A total of 204 drugs are known to interact with Dexmethylphenidate / serdexmethylphenidate:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 13, 2001 |
March 02, 2021 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.